{"id":"NCT02273167","sponsor":"Norgine","briefTitle":"Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREPÂ® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.","officialTitle":"A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus MOVIPREP Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2015-08","completion":"2015-08","firstPosted":"2014-10-23","resultsPosted":"2017-04-18","lastUpdate":"2018-05-15"},"enrollment":849,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"SCREENING"},"conditions":["Colorectal Cancer","Colorectal Carcinoma","Colon Cleansing"],"interventions":[{"type":"DRUG","name":"NER1006, 2-Day Split-Dosing","otherNames":[]},{"type":"DRUG","name":"NER1006,1-Day Morning Split-Dosing","otherNames":[]},{"type":"DRUG","name":"MOVIPREP, 2-Day Split-Dosing","otherNames":[]}],"arms":[{"label":"NER1006, 2-Day Split-Dosing","type":"EXPERIMENTAL"},{"label":"NER1006,1-Day Morning Split-Dosing","type":"EXPERIMENTAL"},{"label":"MOVIPREP, 2-Day Split-Dosing","type":"ACTIVE_COMPARATOR"}],"summary":"This study evaluates the efficacy, safety and tolerability of NER1006 versus MOVIPREP in adult patients requiring bowel cleansing prior to any procedure that requires a clean bowel, using a 2-Day evening/morning Split-Dosing and 1-Day morning only Split-Dosing regimens. Approximately 810 patients will be randomised with the aim of achieving a minimum of 245 patients in each of the 3 groups.","primaryOutcome":{"measure":"Number of Patients With Successful Bowel Cleansing (Overall Colon)","timeFrame":"Up to 2 days (from day of first dosing to day of colonoscopy)","effectByArm":[{"arm":"MOVIPREP, 2-Day Split-Dosing","deltaMin":238,"sd":null},{"arm":"NER1006, 2-Day Split-Dosing","deltaMin":253,"sd":null},{"arm":"NER1006,1-Day Morning Split-Dosing","deltaMin":245,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.055"},{"comp":"OG000 vs OG002","p":"0.328"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":24},"locations":{"siteCount":29,"countries":["Belgium","France","Germany","Italy","Poland","Spain","United Kingdom"]},"refs":{"pmids":["36064325","30025414"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":263},"commonTop":["Nausea","Vomiting","Abdominal pain","Headache","Thirst"]}}